Skip to main content

ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer.

Publication ,  Journal Article
McLaughlin, PW; Liss, AL; Nguyen, PL; Assimos, DG; D'Amico, AV; Gottschalk, AR; Gustafson, GS; Keole, SR; Liauw, SL; Lloyd, S; Movsas, B ...
Published in: Am J Clin Oncol
February 2017

PURPOSE: To present the most updated American College of Radiology consensus guidelines formed from an expert panel on treatment of locally advanced, high-risk prostate cancer METHODS:: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment. RESULTS: The panel summarized the most recent and relevant literature on the topic and voted on 4 clinical variants illustrating the appropriate management of locally advanced, high-risk cancer. Numerical rating and commentary reflecting the panel consensus was given for each treatment approach in each variant. CONCLUSIONS: Aggressive local approaches including surgery followed by adjuvant XRT, beam combined with androgen deprivation therapy, and beam combined with brachytherapy have resulted in unpresented success in locally advanced, high-risk prostate cancer. By combining most recent medical literature and expert opinion, this guideline can aid clinicians in the appropriate integration of available therapeutic modalities.

Duke Scholars

Published In

Am J Clin Oncol

DOI

EISSN

1537-453X

Publication Date

February 2017

Volume

40

Issue

1

Start / End Page

1 / 10

Location

United States

Related Subject Headings

  • Risk Assessment
  • Radiotherapy
  • Prostatic Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Male
  • Humans
  • Combined Modality Therapy
  • 3211 Oncology and carcinogenesis
  • 1105 Dentistry
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McLaughlin, P. W., Liss, A. L., Nguyen, P. L., Assimos, D. G., D’Amico, A. V., Gottschalk, A. R., … Expert Panel on Radiation OncologyProstate. (2017). ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer. Am J Clin Oncol, 40(1), 1–10. https://doi.org/10.1097/COC.0000000000000354
McLaughlin, Patrick W., Adam L. Liss, Paul L. Nguyen, Dean G. Assimos, Anthony V. D’Amico, Alexander R. Gottschalk, Gary S. Gustafson, et al. “ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer.Am J Clin Oncol 40, no. 1 (February 2017): 1–10. https://doi.org/10.1097/COC.0000000000000354.
McLaughlin PW, Liss AL, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, et al. ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer. Am J Clin Oncol. 2017 Feb;40(1):1–10.
McLaughlin, Patrick W., et al. “ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer.Am J Clin Oncol, vol. 40, no. 1, Feb. 2017, pp. 1–10. Pubmed, doi:10.1097/COC.0000000000000354.
McLaughlin PW, Liss AL, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, Movsas B, Prestidge BR, Showalter TN, Taira AV, Vapiwala N, Davis BJ, Expert Panel on Radiation OncologyProstate. ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer. Am J Clin Oncol. 2017 Feb;40(1):1–10.

Published In

Am J Clin Oncol

DOI

EISSN

1537-453X

Publication Date

February 2017

Volume

40

Issue

1

Start / End Page

1 / 10

Location

United States

Related Subject Headings

  • Risk Assessment
  • Radiotherapy
  • Prostatic Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Male
  • Humans
  • Combined Modality Therapy
  • 3211 Oncology and carcinogenesis
  • 1105 Dentistry